Single Oral Doses Study of Nerispirdine on Visual Function in Patients With Multiple Sclerosis

NCT00772525 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis
Optic Nerve
Neuritis

Interventions

DRUG: Nerispirdine
DRUG: Placebo

Sponsor

Sanofi